Temporally controlled prostate epithelium-specific gene alterations

Genesis

Volumn 46, Issue 4, 2008, Pages 229-234

  Luchman, H Artee ^a   Friedman, Hana C ^b   Villemaire, Michelle L ^a   Peterson, Alan C ^b   Jirik, Frank R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

ARR2PB promoter; CreER(T2); HPRT locus; Mouse model; Prostate cancer

Indexed keywords

BETA ARRESTIN 2; BETA GALACTOSIDASE; CRE RECOMBINASE; HORMONE; HYBRID PROTEIN; PROBASIN; RECOMBINASE; TAMOXIFEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENE MUTATION; HISTORY; MALE; MODEL; MONITORING; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIUM; GENE TRANSFER TECHNIQUES; MALE; MICE; MICE, TRANSGENIC; PROSTATE; PROSTATIC NEOPLASMS; RATS;

MURINAE; MUS; RATTUS;

EID: 43949083383     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20386     Document Type: Article

References (22)

1. Abate-Shen C, Shen MM. 2002. Mouse models of prostate carcinogenesis. Trends Genet 18:S1-S5.
2. American Cancer Society. 2006. Cancer Facts and Figures. Atlanta: American Cancer Society.
3. Backman SA, Ghazarian D, So K, Sanchez O, Wagner KU, Hennighausen L, Suzuki A, Tsao MS, Chapman WB, Stambolic V, Mak TW. 2004. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA 101:1725-1730.
4. Bronson SK, Plaehn EG, Kluckman KD, Hagaman JR, Maeda N, Smithies O. 1996. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93:9067-9072.
5. Carver BS, Pandolfi PP. 2006. Mouse modeling in oncologic preclinical and translational research. Clin Cancer Res 12:5274-5276.
6. Cleutjens KB, van der Korput HA, Ehren-van Eekelen CC, Sikes RA, Fasciana C, Chung LW, Trapman J. 1997. 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol Endocrinol 11:1256-1265.
7. Farhadi HF, Lepage P, Forghani R, Friedman HC, Orfali W, Jasmin L, Miller W, Hudson TJ, Peterson AC. 2003. A combinatorial network of evolutionarily conserved myelin basic protein regulatory sequences confers distinct glial-specific phenotypes. J Neurosci 23:10214-10223.
8. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM. 1995. Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443.
9. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM. 1994. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8:230-239.
10. Imai T, Jiang M, Chambon P, Metzger D. 2001. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor α mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc Natl Acad Sci USA 98:224-228.
11. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER recombinases. Nucleic Acids Res 27:4324-4327.
12. Kasper S, Rennie PS, Bruchovsky N, Sheppard PC, Cheng H, Lin L, Shiu RP, Snoek R, Matusik RJ. 1994. Cooperative binding of androgen receptors to two DNA sequences is required for androgen induction of the probasin gene. J Biol Chem 269:31763-31769.
13. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P, Cleutjens KB, de Krijger R, Krimpenfort P, Berns A, van der Kwast TH, Trapman J. 2005. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 65:5730-5739.
14. Odgren PR, MacKay CA, Mason-Savas A, Yang M, Mailhot G, Birnbaum MJ. 2006. False-positive β-galactosidase staining in osteoclasts by endogenous enzyme: Studies in neonatal and month-old wild-type mice. Connect Tissue Res 47:229-234.
15. Schuler M, Ali F, Metzger E, Chambon P, Metzger D. 2005. Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouse. Genesis 41:165-170.
16. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, Costantini F. 2001. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:4.
17. Srinivasan G, Campbell E, Bashirelahi N. 1995. Androgen, estrogen, and progesterone receptors in normal and aging prostates. Microsc Res Technol 30:293-304.
18. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, Xiao A, Khoo AS, Roy-Burman P, Greenberg NM, Van Dyke T, Cordon-Cardo C, Pandolfi PP. 2003. Pten dose dictates cancer progression in the prostate. PLoS Biol 1:E59.
19. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H. 2003. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209-221.
20. Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ, Sangiorgi FO, Maxson RE, Sucov HM, Roy-Burman P. 2001. Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101:61-69.
21. Yan Y, Sheppard PC, Kasper S, Lin L, Hoare S, Kapoor A, Dodd JG, Duckworth ML, Matusik RJ. 1997. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. Prostate 32:129-139.
22. Zhang J, Thomas TZ, Kasper S, Matusik RJ. 2000. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 141:4698-4710.